US-China Biomedical Technology, Inc. Stock-Based Compensation
US-China Biomedical Technology, Inc. reported Stock-Based Compensation of $0 for the 9-month period ending 2015-11-30, per its 10-Q filed 2016-01-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2016-01-08
- US-China Biomedical Technology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2015-11-30 was $0.00.
- US-China Biomedical Technology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2014-11-30 was $0.00, a 100.00% decline year-over-year.
- US-China Biomedical Technology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2013-11-30 was $88.75K.
- US-China Biomedical Technology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2013-08-31 was $35.00K.
- US-China Biomedical Technology, Inc. share-based payment arrangement, noncash expense for fiscal 2013 was $20.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 16 month | Share-based Payment Arrangement, Noncash Expense 19 month | Share-based Payment Arrangement, Noncash Expense 22 month | Share-based Payment Arrangement, Noncash Expense 25 month |
|---|---|---|---|---|---|---|---|---|
| 2015-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-01-08 | $0.00 10-Q · filed 2016-01-08 | ||||||
| 2015-08-31 | $0.00 10-Q · filed 2015-10-09 | |||||||
| 2014-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-01-08 | $34.50K 10-Q · filed 2016-01-08 | ||||||
| 2014-08-31 | $34.50K 10-Q · filed 2015-10-09 | |||||||
| 2013-11-30 | $88.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-01-14 | $123.75K derived: sum of 2 quarters · filed 2014-01-14 | $278.50K 10-Q · filed 2014-01-14 | $278.50K derived: sum of 4 quarters · filed 2014-01-14 | $298.50K 10-Q · filed 2014-01-14 | |||
| 2013-08-31 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-15 | $189.75K 10-Q · filed 2013-10-15 | $189.75K derived: sum of 3 quarters · filed 2013-10-15 | $189.75K derived: sum of 4 quarters · filed 2014-01-14 | $209.75K 10-Q · filed 2013-10-15 | |||
| 2013-05-31 | $154.75K 10-Q · filed 2013-07-22 | $154.75K derived: sum of 2 quarters · filed 2013-07-22 | $154.75K derived: sum of 3 quarters · filed 2014-01-14 | $154.75K derived: sum of 4 quarters · filed 2014-01-14 | $174.75K 10-Q · filed 2013-07-22 | |||
| 2013-02-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-29 | $0.00 derived: sum of 2 quarters · filed 2014-01-14 | $0.00 derived: sum of 3 quarters · filed 2014-01-14 | $20.00K 10-K · filed 2013-05-29 | $20.00K 10-K · filed 2013-05-29 | |||
| 2012-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-01-14 | $0.00 derived: sum of 2 quarters · filed 2014-01-14 | $20.00K 10-Q · filed 2014-01-14 | |||||
| 2012-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-15 | $20.00K 10-Q · filed 2013-10-15 | ||||||
| 2012-05-31 | $20.00K 10-Q · filed 2013-07-22 |